Comparing Monovisc vs Zilretta
| Monovisc (hyaluronan) | Zilretta (triamcinolone) |
|
|---|
| Monovisc (hyaluronan) | Zilretta (triamcinolone) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Osteoarthritis. Monovisc may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Osteoarthritis. Zilretta may also be used for purposes not listed in this medication guide. |
Related suggestions Osteoarthritis
Popular comparisons
|
|||||||
| More about Monovisc (hyaluronan) | More about Zilretta (triamcinolone) | ||||||||
| Ratings & Reviews | |||||||||
|
Monovisc has an average rating of 5.6 out of 10 from a total of 65 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 40% reported a negative effect. |
Zilretta has an average rating of 6.0 out of 10 from a total of 57 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 40% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Monovisc side effects |
View all Zilretta side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Zilretta prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Other hyaluronan brands include: Hymovis, Orthovisc | Other triamcinolone brands include: Aristospan, Aristospan Intra-Articular, Aristospan Intralesional, Clinacort, Kenalog-10, Kenalog-40 | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
36 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 14 drugs are known to interact with Monovisc:
|
A total of 615 drugs are known to interact with Zilretta:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
|
|||||||||
| First Approval Date | |||||||||
|
N/A |
October 06, 2017 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
|||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.